Clusterin Interacts with Paclitaxel and Confer Paclitaxel Resistance in Ovarian Cancer

Abstract excerpt

Optimal debulking followed by chemotherapy is the standard treatment of managing late-stage ovarian cancer, but chemoresistance is still a major problem. In this study, we compared expression profiles of primary tumor tissue from five long-term (>8 years) and five short-term (<2 years) ovarian cancer survivors and identified clusterin as one of the genes that were significantly up-regulated in short-term...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Caveolin-1 and cellular processes
• Share to Clusterin in disease pathology
• Share to Ferroptosis and cancer prognosis